Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Allarity Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19
Revenues6.914.20.00.1
            Revenue growth-51.2% -100.0% 
Cost of goods sold6.914.20.00.0
Gross profit0.00.00.00.1
            Gross margin0.0%0.0% 100.0%
Research and development  5.16.4
General and administrative10.012.44.13.9
EBIT-16.9-26.6-8.4-10.1
            EBIT margin-243.8%-187.1% -8430.8%
Pre-tax income-17.6-26.5-5.1-14.4
Income taxes-1.50.12.24.6
            Tax rate8.7%   
Net income-16.1-26.6-7.2-18.9
            Net margin-231.7%-187.7% -15741.7%
 
Diluted EPS($0.06)($0.15)($0.04)($0.30)
Shares outstanding (diluted)272.2181.7172.763.4
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy